General MedicationsNASALGeneric
FluMist
Influenza Vaccine Live Intranasal
Standard Dose
Refer to label-specific dosage instructions.
Max Dose
See product label
Primary Use
Marketed spray containing INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN, INFLUENZA A VIRUS A/PERTH/722/2024 (H3N2) LIVE (ATTENUATED) ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN.
Summary
Product profile Marketed spray containing INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN, INFLUENZA A VIRUS A/PERTH/722/2024 (H3N2) LIVE (ATTENUATED) ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN.
Dose form and route SPRAY · NASAL
Structured Monograph
Clinical summary
Product profile Marketed spray containing INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN, INFLUENZA A VIRUS A/PERTH/722/2024 (H3N2) LIVE (ATTENUATED) ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN. Dose form and route SPRAY · NASAL
Monitoring
- • Review the product-specific label before prescribing.
Interaction Notes
- • Interaction data should be confirmed against the corresponding label.